Randomized controlled trials are considered the gold standard in the hierarchy of research
designs for evaluating the efficacy and safety of a treatment intervention. However, their …

Fourteen reports utilizing data from de-identified administrative databases were reviewed.
Studies contained at least one measure of patient persistence or compliance with …

Fragility fractures associated with osteoporosis constitute a significant public health concern.
Clinical trials have shown that a variety of agents—bisphosphonates, raloxifene, calcitonin …

ONJ has been increasingly suspected to be a potential complication of bisphosphonate
therapy in recent years. Thus, the ASBMR leadership appointed a multidisciplinary task …

ContextVertebral fractures significantly increase lifetime risk of future fractures, but risk of
further vertebral fractures in the period immediately following a vertebral fracture has not …

To assess the cost‐effectiveness of interventions to prevent osteoporosis, it is necessary to
estimate total health care expenditures for the treatment of osteoporotic fractures. Resources …

Objective. To determine whether sulfasalazine (SSZ) at a dosage of 2,000 mg/day is
effective for the treatment of active psoriatic arthritis (PsA) resistant to nonsteroidal …

Abstract In this 3‐yr, randomized, double‐blind, placebo‐and active‐controlled study,
healthy postmenopausal women with osteoporosis (55–85 yr of age) were treated with …

Bisphosphonates reduce the rate of osteoporotic fractures in clinical trials and community
practice.“Atypical” nontraumatic fractures of the diaphyseal (subtrochanteric or shaft) part of …

Background: Reducing bisphosphonate dosing frequency may improve suboptimal
adherence to treatment and therefore therapeutic outcomes in postmenopausal …